The advent of the cytokine storm

Immunology and Cell Biology

Volumn 85, Issue 4, 2007, Pages 271-273

  Clark, Ian A ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

CONCENTRATION (PARAMETERS); GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INNATE IMMUNITY; MALARIA; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEPSIS; SHORT SURVEY; SIGNAL TRANSDUCTION; TOXOPLASMA; VIRUS INFECTION;

ANIMALS; COMMUNICABLE DISEASES; CYTOKINES; HUMANS; IMMUNE SYSTEM DISEASES; INFLAMMATION MEDIATORS; MALARIA; SEPSIS; TOXOPLASMA; TUMOR NECROSIS FACTOR-ALPHA; VIRUS DISEASES;

EID: 34249943678     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/sj.icb.7100062     Document Type: Short Survey

References (46)

1. Ferrara JL, Abhyankar S, Gilliland DG. Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1. Transplant Proc 1993; 25: 1216-1217.
2. Clark IA, Alleva LE, Mills AC, Cowden WB. Pathogenesis in malaria and clinically similar conditions. Clin Microbiol Rev 2004; 17: 509-539.
3. Piguet P-F, Grau GE, Allet B, Vassalli P. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs-host disease. J Exp Med 1987; 166: 1280-1289.
4. Makhija R, Kingsnorth AN. Cytokine storm in acute pancreatitis. J Hepatobil Pancreat Surg 2002; 9: 401-410.
5. Exley AR, Leese T, Holliday MP, Swann RA, Cohen J. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut 1992; 33: 1126-1128.
6. Rongione AJ, Kusske AM, Kwan K, Ashley SW, Reber HA, Mcfadden DW. Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology 1997; 112: 960-967.
7. Yokota S. Influenza-associated encephalopathy-pathophysiology and disease mechanisms. Nippon Rinsho 2003; 61: 1953-1958.
8. Jahrling PB, Hensley LE, Martinez MJ, Leduc JW, Rubins KH, Relman DA et al. Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. Proc Natl Acad Sci USA 2004; 101: 15196-15200.
9. Yuen KY, Wong SS. Human infection by avian influenza A H5N1. Hong Kong Med J 2005; 11: 189-199.
10. Clark IA. Cell-mediated immunity in protection and pathology of malaria. Parasitol Today 1987; 3: 300-305.
11. Clark IA, Cowden WB. The pathophysiology of falciparum malaria. Pharmacol Ther 2003; 99: 221-260.
12. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975; 72: 3666-3670.
13. Clark IA, Virelizier J-L, Carswell EA, Wood PR. Possible importance of macrophage-derived mediators in acute malaria. Infect Immun 1981; 32: 1058-1066.
14. Clark IA. Suggested importance of monokines in pathophysiology of endotoxin shock and malaria. Klin Wochenschr 1982; 60: 756-758.
15. Clark IA, Chaudhri G, Cowden WB. Roles of tumour necrosis factor in the illness and pathology of malaria. Trans R Soc Trop Med Hyg 1989; 83: 436-440.
16. Tracey KJ, Lowry SF, Fahey TJ, Albert JD, Fong Y, Hesse D et al. Cachectin/tumor necrosis factor induces lethal shock and stress hormone response in the dog. Surg Gynecol Obstet 1987; 164: 415-422.
17. Kwiatkowski D, Cannon JG, Manogue KR, Cerami A, Dinarello CA, Greenwood BM. Tumor necrosis factor production in falciparum malaria and its association with schizont rupture. Clin Exp Immunol 1989; 77: 361-366.
18. Kwiatkowski D, Hill AVS, Sambou I, Twumasi P, Castracane J, Manogue KR et al. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 1990; 336: 1201-1204.
19. Coxon RE, Fekade D, Knox K, Hussein K, Melka A, Daniel A et al. The effect of antibody against TNF alpha on cytokine response in Jarisch-Herxheimer reactions of louse-borne relapsing fever. Q J Med 1997; 90: 213-221.
20. Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003; 3: 745-756.
21. Creagan ET, Kovach JS, Moertel CG, Frytak S, Kvols LK. A phase 1 clinical trial of recombinant human tumor necrosis factor. Cancer 1988; 62: 2467-2471.
22. Jakubowski AA, Casper ES, Gabrilove JL, Templeton MA, Sherwin SA, Oettgen HF. Phase 1 trial of intramuscularly administered tumor necrosis factor in patients with advanced cancer. J Clin Oncol 1989; 7: 298-303.
23. Clark IA, Gray KM, Rockett EJ, Cowden WB, Rockett KA, Ferrante A et al. Increased lymphotoxin in human malarial serum, and the ability of this cytokine to increase plasma interleukin-6 and cause hypoglycaemia in mice - implications for malarial pathology. Trans R Soc Trop Med Hyg 1992; 86: 602-607.
24. Clark IA, Cowden WB. Is TNF a key to acute infectious illness? Today's Life Sci 1989; 1: 26-29.
25. Schnittler HJ, Mahner F, Drenckhahn D, Klenk HD, Feldmann H. Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease. J Clin Invest 1993; 91: 1301-1309.
26. Feldmann H, Bugany H, Mahner F, Klenk HD, Drenckhahn D, Schnittler HJ. Filovirus-induced endothelial leakage triggered by infected monocytes/ macrophages. J Virol 1996; 70: 2208-2214.
27. Peper RL, Vancampen H. Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia. Microb Pathogen 1995; 19: 175-183.
28. Hinder F, Schmidt A, Gong JH, Bender A, Sprenger H, Nain M et al. Influenza A virus infects macrophages and stimulates release of tumor necrosis factor-alpha. Pathobiology 1991; 59: 227-231.
29. Houde M, Arora DJS. Stimulation of tumor necrosis factor secretion by purified influenza virus neuraminidase. Cell Immunol 1990; 129: 104-111.
30. Cheung CY, Poon LLM, Lau AS, Luk W, Lau YL, Shortridge KF et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease. Lancet 2002; 360: 1831-1837.
31. Chan MCW, Cheung CY, Chui WH, Tsao GSW, Nicholls JM, Chan YO et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Resp Res 2005; 6: 135.
32. Zhou JF, Law HKW, Cheung CY, Ng IHY, Peiris JSM, Lau YL. Functional tumor necrosis factor-related apoptosis-inducing ligand production by avian influenza virus-infected macrophages. J Infect Dis 2006; 193: 945-953.
33. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006; 12: 1203-1207.
34. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, Thomas MJ et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 2006; 443: 578-581.
35. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, Ebihara H et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007; 445: 319-323.
36. La Gruta NL, Kedzierska K, Stambas J, Doherty PC. A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 2007; 85: 85-92.
37. Seo SH, Webster RG. Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells. J Virol 2002; 76: 1071-1076.
38. Vilcek J, Feldmann M. Historical review: cytokines as therapeutics and targets of therapeutics. Trends Pharm Sci 2004; 25: 201-209.
39. Calabrese LH, Zein N, Vassilopoulos D. Safety of anti-tumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection. Ann Rheum Dis 2004; 63: 18-24.
40. Schofield L. Intravascular infiltrates and organ-specific inflammation in malaria pathogenesis. Immunol Cell Biol 2007; 85: 130-137.
41. Clark IA, Budd AC, Alleva LM, Cowden WB. Human malarial disease: a consequence of inflammatory cytokine release. Malar J 2006; 5: 85.
42. Schofield L, Vivas L, Hackett F, Gerold P, Schwarz RT, Tachado S. Neutralizing monoclonal antibodies to glycosylphosphatidylinositol, the dominant TNF-alpha-inducing toxin of Plasmodium falciparum - prospects for the immunotherapy of severe malaria. Ann Trop Med Parasitol 1993; 87: 617-626.
43. Gaddi PJ, Yap GS. Cytokine regulation of immunopathology in toxoplasmosis. Immunol Cell Biol 2007; 85: 155-159.
44. Tachado SD, Gerold P, Schwarz R, Novakovic S, McConville M, Schofield L. Signal transduction in macrophages by glycosylphosphatidylinositols of Plasmodium, Trypanosoma, and Leishmania: activation of protein tyrosine kinases and protein kinase C by inositolglycan and diacylglycerol moieties. Proc Natl Acad Sci USA 1997; 94: 4022-4027.
45. Clark IA. How TNF was recognized to be a key mechanism of disease. Cytokine Growth Factor Rev 2007 (in press).
46. Macdonald G J. How mobile is the earth?. In: Oreski N (ed). Plate Tectonics. Westview Press: Boulder, CO, 2003 pp 111-127.